Legal Representation
Attorney
Francis J. Duffin
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 5, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 5, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 16, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 16, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 9, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 9, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 9, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 22, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Dec 22, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 26, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 26, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 29, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 27, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 27, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 27, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 1, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 29, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 29, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 29, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 3, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 1, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 1, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 1, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 29, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 4, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 4, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 14, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 30, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 30, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 30, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 30, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 30, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 9, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 9, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 5, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 12, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 12, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 12, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 13, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 13, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 13, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 24, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 13, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 4, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"